Yanai Shlomo has filed 11 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 1002 shares of Philip Morris International Inc. ($PM) on May 07, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2025 | Philip Morris International Inc. | $PM | Yanai Shlomo | Director | A | Common Stock | 1002 | $174.82 | 8,759.0000 | 1,556,000,000 | 12.92% | 0.00% |
| May 6, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Yanai Shlomo | Director | A | Restricted Stock Units | 34819 | $0.00 | 34,819.0000 | 308,978,000 | 9999.99% | 0.01% |
| May 5, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Yanai Shlomo | Director | M | Class A Common Stock | 40258 | $0.00 | 285,985.0000 | 308,978,000 | 16.38% | 0.01% |
| May 5, 2025 | Amneal Pharmaceuticals, Inc. | $AMRX | Yanai Shlomo | Director | M | Restricted Stock Units | 40258 | $0.00 | 0.0000 | 308,978,000 | 100.00% | 0.01% |
| May 10, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Yanai Shlomo | Director | M | Class A Common Stock | 76453 | $0.00 | 245,727.0000 | 176,136,000 | 45.17% | 0.04% |
| May 10, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Yanai Shlomo | Director | M | Restricted Stock Units | 76453 | $0.00 | 0.0000 | 176,136,000 | 100.00% | 0.04% |
| May 8, 2024 | Philip Morris International Inc. | $PM | Yanai Shlomo | Director | A | Common Stock | 1789 | $97.84 | 7,501.0000 | 1,553,000,000 | 31.32% | 0.00% |
| May 2, 2024 | Amneal Pharmaceuticals, Inc. | $AMRX | Yanai Shlomo | Director | A | Restricted Stock Units | 40258 | $0.00 | 40,258.0000 | 176,136,000 | 9999.99% | 0.02% |
| May 10, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Yanai Shlomo | Director | M | Restricted Stock Units | 80128 | $0.00 | 0.0000 | 150,944,000 | 100.00% | 0.05% |
| May 10, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Yanai Shlomo | Director | M | Class A Common Stock | 80128 | $0.00 | 169,274.0000 | 150,944,000 | 89.88% | 0.05% |
| May 9, 2023 | Amneal Pharmaceuticals, Inc. | $AMRX | Yanai Shlomo | Director | A | Restricted Stock Units | 76453 | $0.00 | 76,453.0000 | 150,944,000 | 9999.99% | 0.05% |